Diversity in Clinical Trials

Clinical trials are used to evaluate the safety and effectiveness of potential medications by monitoring their effects in individuals who volunteer to participate. 

Learn More

Why it Matters

Research has demonstrated that biological differences can influence how people process medicines.  For example, differences in genetic coding can make a cancer treatment more toxic in one ethnic group than it would in another. These differences can also make drugs like antidepressants and blood pressure medications less effective in some races and ethnicities.

According to the Food and Drug Administration (FDA), increased diversity in clinical trials could help researchers find better ways to fight diseases that disproportionately impact certain populations.

Did You Know?

Hispanics are most disproportionately affected by asthma, cancer, diabetes and heart disease.

Asian Americans are disproportionately affected by chronic obstructed pulmonary disease (COPD), hepatitis B and tuberculosis.

African Americans are most disproportionately affected by cancer, cardiovascular disease, stroke and diabetes.

Interested in learning more?

Contact us at contactSHC@SHCllc.info